Namwiwat Medical
Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. It also offers equipment rental and contractual construction services. The company was formerly known as Namwiwat Engineering (199… Read more
Namwiwat Medical (NAM) - Total Liabilities
Latest total liabilities as of June 2024: ฿389.54 Million THB
Based on the latest financial reports, Namwiwat Medical (NAM) has total liabilities worth ฿389.54 Million THB as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Namwiwat Medical - Total Liabilities Trend (2021–2024)
This chart illustrates how Namwiwat Medical's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Namwiwat Medical Competitors by Total Liabilities
The table below lists competitors of Namwiwat Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EarthRenew Inc
PINK:VVIVF
|
USA | $11.61 Million |
|
Kalyani Forge Limited
NSE:KALYANIFRG
|
India | ₹1.67 Billion |
|
Minrex Resources Ltd
AU:MRR
|
Australia | AU$178.64K |
|
Hsin-Sin Textile Co Ltd
TWO:4406
|
Taiwan | NT$331.35 Million |
|
Ebusco Holding BV
AS:EBUS
|
Netherlands | €167.07 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Namwiwat Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Namwiwat Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Namwiwat Medical (2021–2024)
The table below shows the annual total liabilities of Namwiwat Medical from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | ฿386.93 Million | -20.55% |
| 2023-06-30 | ฿487.03 Million | -21.58% |
| 2022-06-30 | ฿621.07 Million | +10.16% |
| 2021-06-30 | ฿563.80 Million | -- |